The current pandemic has drawn attention to China's actual death rate and raised questions about medical supplies. The State Council held a press briefing in response to these concerns. Wu Zunyou, chief epidemiologist at the Chinese CDC, and Liang Wannian, head of the COVID-...
Mutant Strains Of Covid-19 And Current Status Of Vaccines -- A Systematic ReviewSOMASUNDARAM. P.SHANMUGASUNDARAMInternational Journal of Pharmaceutical Research (09752366)
As the use of this platform has increased with the rollout of the ChAdOx COVID-19 vaccine and potential future use of the vector, particularly for viruses and other pathogens endemic to the same areas i.e. Ebola, LASV and Malaria, vector-specific immunity and its potential role in vaccine...
2024, MedComm Novel Administration Routes, Delivery Vectors, and Application of Vaccines Based on Biotechnologies: A Review 2024, Vaccines Viral infections causing asthma exacerbations in the age of biologics and the COVID-19 pandemic 2024, Current Opinion in Pulmonary Medicine What is the role of ...
The COVID-19 pandemic exposed a world surprisingly unprepared to respond to the new epidemiological scenario, even the developed countries, in spite of war... C Possas,ETA Marques,JB Risi,... - 《Circular Economy & Sustainability》 被引量: 0发表: 2021年 Are we prepared for the next influe...
During the COVID-19 pandemic, the traditional herbal medicine Artemisia afra Jacq. ex Willd., Asteraceae, was widely used as a remedy, and a true media sto
A critical overview of current progress for COVID-19: development of vaccines, antiviral drugs, and therapeutic antibodies Article Open access 12 September 2022 COVID-19 drug discovery and treatment options Article 15 April 2024 A Comprehensive Review of COVID-19 Virology, Vaccines, Variants, ...
In addition, there is still neutralizing activity against the Delta (B.1.617.2) variation, but it is not as strong as it was against the Omicron (B.1.1.529) strains that were circulating before (https://www.who.int/publications/m/item/draft-landscape-of-COVID-19-candidate-vaccines) (...
Currently available vaccines against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) are highly effective but not able to keep the coronavirus disease 2019 (COVID-19) pandemic completely under control. Alternative R&D strategies are required to induce a long-lasting immunological response ...
The discovery of novel viruses and the resurgence of established strains heighten concerns about their implications for reproduction. In the aftermath of COVID-19, research efforts have intensified to broaden the understanding of the severe acute respiratory syndrome coronavirus-2's (SARS-CoV-2) ...